Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen

Alexandros Ardavanis, Panteleimon Kountourakis, Ioannis Mantzaris, Savvoula Malliou, Dimitrios Doufexis, Despina Sykoutri, Ioannis Fragos, Gerassimos Rigatos

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen'. Together they form a unique fingerprint.

Medicine & Life Sciences